Silexion Therapeutics Corp. Insider Trading
SLXN
Insiders sold 31K and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. CSO and CDO Mitchell Shirvan sold 31K on Mar 26, 45% of their stake, outside a plan. No executive or director has bought shares on the open market in the last two years.
Get an email when SLXN's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Mar 26 | Mitchell Shirvan CSO and CDO | SoldNo plan | 22,818 | $1.36 | 31K | 45% | Form 4 |
- Mar 26No planMitchell ShirvanCSO and CDO · sold 22,818 at $1.3631K45% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with SLXN
Spot a number that looks wrong? Check it in SLXN's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing SLXN
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.